Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04678284 · ClinicalTrials.gov registry record · NA
Diabetes Homeless Medication Support Single Arm Treatment Development Trial
A NA study of Type 2 Diabetes and Homeless Persons, sponsored by Hennepin Healthcare Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04678284: Completed NA study of Type 2 Diabetes and Homeless Persons, sponsored by Hennepin Healthcare Research Institute.
NCT04678284 is a NA study of Type 2 Diabetes and Homeless Persons that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 10 participants, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04678284, a NA study of Type 2 Diabetes and Homeless Persons, has completed, sponsored by Hennepin Healthcare Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-arm trial of the Diabetes Homeless Medication Support intervention alone (n=15) will test the perception and feasibility of anticipated study procedures.
Primary Outcome
Client Satisfaction Questionnaire, 8-item version, with a score range from 8-32, higher score indicating higher satisfaction.
Conditions Studied
Interventions
- BEHAVIORAL Diabetes Homeless Medication Support (D-Homes)
Study Locations (1)
Minnesota
- Hennepin Healthcare - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-03-24 |
| Est. Completion | 2022-03-24 |
| Phase | NA |
What the finished NCT04678284 record still lists
NCT04678284 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Diabetes Homeless Medication Support (D-Homes) is the first listed.
NCT04678284 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04678284 about?
NCT04678284 is a clinical study titled "Diabetes Homeless Medication Support Single Arm Treatment Development Trial". This single-arm trial of the Diabetes Homeless Medication Support intervention alone (n=15) will test the perception and feasibility of anticipated study procedures.
What is the current status of trial NCT04678284?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-03-24. Estimated completion is 2022-03-24.
What conditions does trial NCT04678284 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Homeless Persons.
What interventions are being tested in trial NCT04678284?
The interventions under investigation include: Diabetes Homeless Medication Support (D-Homes) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04678284?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04678284 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04678284's enrollment target sits among peer trials
10 321st of 327 higher than 4 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI